Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

E. M. KRUPITSKY ; E. V. NUNES ; W. LING ; A. ILLEPERUMA ; D. R. GASTFRIEND ; B. L. SILVERMAN | 2011
Dans Lancet (The) (Vol.377, n°9776, Apr 30, 2011) Article : Périodique

BACKGROUND Opioid dependence is associated with low rates of treatment-seeking, poor adherence to treatment, frequent relapse, and major societal consequences. We aimed to assess the efficacy, safety, and patient-reported outcomes of an injectab[...]

Plus d'info

Ajouter à la sélection